Literature DB >> 26358578

Sarcopenia and failure to rescue following liver transplantation.

Patrick W Underwood1, David C Cron1, Michael N Terjimanian1, Stewart C Wang1,2, Michael J Englesbe1,2, Seth A Waits2.   

Abstract

INTRODUCTION: Sarcopenic liver transplant recipients have higher rates of mortality, but mechanisms underlying these rates remain unclear. Failure to rescue (FTR) has been shown to be a primary driver of mortality following major general and vascular surgery. We hypothesized that FTR is common in sarcopenic liver transplant recipients.
METHODS: We retrospectively reviewed 348 liver transplant recipients with perioperative CT scans. Analytic morphomic techniques were used to assess trunk muscle size via total psoas area (TPA). One-yr major complication and FTR rates were calculated across TPA tertiles.
RESULTS: The one-yr complication rate was 77% and the FTR rate was 19%. Multivariate regression showed TPA as a significant predictor of FTR (OR = 0.27 per 1000 mm(2) increase in TPA, p < 0.001). Compared to patients in the largest muscle tertile, patients in the smallest tertile had 1.4-fold higher adjusted complication rates (91% vs. 66%) and 2.8-fold higher adjusted FTR rates (22% vs. 8%). DISCUSSION: These results suggest that mortality in sarcopenic liver transplant recipients may be strongly related to FTR. Efforts aimed at early recognition and management of complications may decrease postoperative mortality. Additionally, this work highlights the need for expanded multicenter collaborations aimed at collection and analysis of postoperative complications in liver transplant recipients.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  complications; failure to rescue; frailty; liver transplantation; outcomes

Mesh:

Year:  2015        PMID: 26358578     DOI: 10.1111/ctr.12629

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  15 in total

Review 1.  Reconsideration of frailty in relation to surgical indication.

Authors:  Kay Maeda; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-23

2.  Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.

Authors:  Heather A Lillemoe; Rebecca K Marcus; Bradford J Kim; Nisha Narula; Catherine H Davis; Qiuling Shi; Xin Shelley Wang; Thomas A Aloia
Journal:  Ann Surg Oncol       Date:  2019-08-14       Impact factor: 5.344

Review 3.  Cause and management of muscle wasting in chronic liver disease.

Authors:  Srinivasan Dasarathy
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

Review 4.  Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?

Authors:  Guido Stirnimann; Maryam Ebadi; Puneeta Tandon; Aldo J Montano-Loza
Journal:  Curr Gastroenterol Rep       Date:  2018-09-26

5.  Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial.

Authors:  Estella M Alonso; Wen Ye; Kieran Hawthorne; Veena Venkat; Kathleen M Loomes; Cara L Mack; Paula M Hertel; Saul J Karpen; Nanda Kerkar; Jean P Molleston; Karen F Murray; Rene Romero; Philip Rosenthal; Kathleen B Schwarz; Benjamin L Shneider; Frederick J Suchy; Yumirle P Turmelle; Kasper S Wang; Averell H Sherker; Ronald J Sokol; Jorge A Bezerra; John C Magee
Journal:  J Pediatr       Date:  2018-09-21       Impact factor: 4.406

6.  Sarcopenia in Liver Transplantation.

Authors:  John Montgomery; Michael Englesbe
Journal:  Curr Transplant Rep       Date:  2019-01-21

7.  Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.

Authors:  William H Jin; Eric A Mellon; Jessica M Frakes; Gilbert Z Murimwa; Pamela J Hodul; Jose M Pimiento; Mokenge P Malafa; Sarah E Hoffe
Journal:  J Gastrointest Oncol       Date:  2018-02

8.  Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.

Authors:  Hani Oweira; Mahmoud Sadeghi; Daniel Volker; Markus Mieth; Ahmed Zidan; Elias Khajeh; Omid Ghamarnejad; Hamidreza Fonouni; Karl Heinz Weiss; Jan Schmidt; Imad Lahdou; Arianeb Mehrabi
Journal:  Ann Transplant       Date:  2018-06-08       Impact factor: 1.530

9.  Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease.

Authors:  Nicholas C Wang; Peng Zhang; Elliot B Tapper; Sameer Saini; Stewart C Wang; Grace L Su
Journal:  Am J Gastroenterol       Date:  2020-08       Impact factor: 12.045

10.  Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure.

Authors:  Cornelius Engelmann; Karen Louise Thomsen; Nekisa Zakeri; Mohammed Sheikh; Banwari Agarwal; Rajiv Jalan; Rajeshwar P Mookerjee
Journal:  Crit Care       Date:  2018-10-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.